Works matching AU Agbarya, Abed
Results: 41
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1T315I and BCR-ABL1T315I-E255K.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 8, p. 2023, doi. 10.1007/s00277-020-04357-z
- By:
- Publication type:
- Article
Real-World Clinical Outcomes of Neoadjuvant Platinum-Based Chemotherapy with Nivolumab in Non-Small Cell Lung Cancer.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 21, p. 6568, doi. 10.3390/jcm13216568
- By:
- Publication type:
- Article
Unexpected and Rare Sites of Metastasis in Oncologic Patients.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 20, p. 6447, doi. 10.3390/jcm12206447
- By:
- Publication type:
- Article
FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC).
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2475, doi. 10.3390/jcm11092475
- By:
- Publication type:
- Article
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 6, p. 1738, doi. 10.3390/jcm11061738
- By:
- Publication type:
- Article
Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 23, p. 5614, doi. 10.3390/jcm10235614
- By:
- Publication type:
- Article
Prospective Observational Study of COVID-19 Vaccination in Patients with Thoracic Malignancies: Adverse Events, Breakthrough Infections and Survival Outcomes.
- Published in:
- Biomedicines, 2024, v. 12, n. 3, p. 535, doi. 10.3390/biomedicines12030535
- By:
- Publication type:
- Article
Multi-Center Real-World Outcomes of Nivolumab Plus Ipilimumab and Chemotherapy in Patients with Metastatic Non-Small-Cell Lung Cancer.
- Published in:
- Biomedicines, 2023, v. 11, n. 9, p. 2438, doi. 10.3390/biomedicines11092438
- By:
- Publication type:
- Article
Factors Predicting Type I Gastric Neuroendocrine Neoplasia Recurrence: A Single-Center Study.
- Published in:
- Biomedicines, 2023, v. 11, n. 3, p. 828, doi. 10.3390/biomedicines11030828
- By:
- Publication type:
- Article
Treatment of Rare Mutations in Patients with Lung Cancer.
- Published in:
- Biomedicines, 2021, v. 9, n. 5, p. 534, doi. 10.3390/biomedicines9050534
- By:
- Publication type:
- Article
Efficacy and Safety of BRAF Inhibitors With or Without MEK Inhibitors in BRAF-Mutant Advanced Non-Small-Cell Lung Cancer: Findings From a Real-Life Cohort.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Versus Pathological Staging in Patients with Resected Ground Glass Pulmonary Lesions.
- Published in:
- Diagnostics (2075-4418), 2024, v. 14, n. 24, p. 2874, doi. 10.3390/diagnostics14242874
- By:
- Publication type:
- Article
Characterizing changes in executive functions and performance in daily activities after chemotherapy: A pre-post mixed-methods study protocol.
- Published in:
- PLoS ONE, 2024, v. 19, n. 12, p. 1, doi. 10.1371/journal.pone.0314551
- By:
- Publication type:
- Article
Transanal Endoscopic Microsurgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer.
- Published in:
- Journal of Laparoendoscopic & Advanced Surgical Techniques, 2015, v. 25, n. 8, p. 617, doi. 10.1089/lap.2014.0647
- By:
- Publication type:
- Article
Oncology Treatments during the COVID-19 Pandemic in Israel: the ONCOR Study.
- Published in:
- Israel Medical Association Journal, 2021, v. 23, n. 12, p. 759
- By:
- Publication type:
- Article
Crizotinib in MET Exon 14-Mutated or MET-Amplified in Advanced Disease Non-Small Cell Lung Cancer: A Retrospective, Single Institution Experience.
- Published in:
- Oncology, 2022, v. 100, n. 9, p. 467, doi. 10.1159/000525188
- By:
- Publication type:
- Article
Natural products as potential cancer herapy enhancers: A preclinical update.
- Published in:
- SAGE Open Medicine, 2014, v. 2, p. 1, doi. 10.1177/2050312114546924
- By:
- Publication type:
- Article
Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/681653
- By:
- Publication type:
- Article
Biological insights from plasma proteomics of non-small cell lung cancer patients treated with immunotherapy.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1364473
- By:
- Publication type:
- Article
Primary Papillary Serous Carcinoma of the Fallopian Tube Presenting as a Vaginal Mass: A Case Report and Review of the Literature.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Attitudes Among Nurses Toward the Integration of Complementary Medicine Into Supportive Cancer Care.
- Published in:
- Oncology Nursing Forum, 2017, v. 44, n. 4, p. 428, doi. 10.1188/17.ONF.428-434
- By:
- Publication type:
- Article
Real-World Experience in Treatment of Patients with Non-Small-Cell Lung Cancer with BRAF or cMET Exon 14 Skipping Mutations.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 16, p. 12840, doi. 10.3390/ijms241612840
- By:
- Publication type:
- Article
Lower lung cancer rates in Jewish smokers in Israel and the USA.
- Published in:
- International Journal of Cancer, 2015, v. 137, n. 9, p. 2155, doi. 10.1002/ijc.29587
- By:
- Publication type:
- Article
First line Immunotherapy for Non-Small Cell Lung Cancer.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 373, doi. 10.3390/ph13110373
- By:
- Publication type:
- Article
A Single-Center Experience in Combined Oncological–Surgical Treatment for Resectable Locally Advanced Non-Small Cell Lung Cancer (NSCLC).
- Published in:
- Diseases, 2024, v. 12, n. 5, p. 98, doi. 10.3390/diseases12050098
- By:
- Publication type:
- Article
Response Rate of the Third and Fourth Doses of the BNT162b2 Vaccine Administered to Cancer Patients Undergoing Active Anti-Neoplastic Treatments.
- Published in:
- Diseases, 2023, v. 11, n. 4, p. 128, doi. 10.3390/diseases11040128
- By:
- Publication type:
- Article
The Nazareth Community Oncology Unit: The oncology nurse's role to provide care in the environment of COVID-19.
- Published in:
- Clinical Journal of Oncology Nursing, 2021, v. 25, n. 3, p. 347, doi. 10.1188/21.CJON.347-350
- By:
- Publication type:
- Article
The Impact of Comprehensive Genomic Profiling (CGP) on the Decision-Making Process in the Treatment of ALK-Rearranged Advanced Non-Small Cell Lung Cancer (aNSCLC) After Failure of 2<sup>nd</sup>/3<sup>rd</sup>-Generation ALK Tyrosine Kinase Inhibitors (TKIs)
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.874712
- By:
- Publication type:
- Article
Overcoming Chemoresistance in Cancer: The Promise of Crizotinib.
- Published in:
- Cancers, 2024, v. 16, n. 13, p. 2479, doi. 10.3390/cancers16132479
- By:
- Publication type:
- Article
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status.
- Published in:
- Cancers, 2024, v. 16, n. 10, p. 1825, doi. 10.3390/cancers16101825
- By:
- Publication type:
- Article
Efficacy of the mRNA-Based BNT162b2 COVID-19 Vaccine in Patients with Solid Malignancies Treated with Anti-Neoplastic Drugs.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4191, doi. 10.3390/cancers13164191
- By:
- Publication type:
- Article
Adjuvant Treatment with Tyrosine Kinase Inhibitors in Epidermal Growth Factor Receptor Mutated Non-Small-Cell Lung Carcinoma Patients, Past, Present and Future.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4119, doi. 10.3390/cancers13164119
- By:
- Publication type:
- Article
Potential Mechanisms of Cancer-Related Hypercoagulability.
- Published in:
- Cancers, 2020, v. 12, n. 3, p. 566, doi. 10.3390/cancers12030566
- By:
- Publication type:
- Article
Novel nanotech antioxidant cocktail prevents medical diagnostic procedures ionizing radiation effects.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-84596-w
- By:
- Publication type:
- Article
Alternative nivolumab duration and scheduling in advanced nonsmall cell lung cancer: A real‐world evidence.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 5, p. 1183, doi. 10.1002/ijc.33281
- By:
- Publication type:
- Article
Arab male physicians' perceptions about their own smoking behaviors: a qualitative study.
- Published in:
- Israel Journal of Health Policy Research, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s13584-024-00602-2
- By:
- Publication type:
- Article
Non-Small-Cell Lung Cancer Patients Harboring ROS1 Rearrangement: Real World Testing Practices, Characteristics and Treatment Patterns (ROS1REAL Study).
- Published in:
- Current Oncology, 2024, v. 31, n. 8, p. 4369, doi. 10.3390/curroncol31080326
- By:
- Publication type:
- Article
Is Elevation of Alkaline Phosphatase a Predictive Factor of Response to Alectinib in NSCLC?
- Published in:
- Current Oncology, 2022, v. 29, n. 1, p. 173, doi. 10.3390/curroncol29010016
- By:
- Publication type:
- Article
Impact of acupuncture and integrative therapies on chemotherapy-induced peripheral neuropathy: A multicentered, randomized controlled trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The Correlation between Proliferative Immunohistochemical Markers and Papillary Thyroid Carcinoma Aggressiveness.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 1, p. 110, doi. 10.3390/medicina59010110
- By:
- Publication type:
- Article
Acupuncture in the Treatment of Panitumumab Skin Toxicity: A Case Report.
- Published in:
- Complementary Medicine Research, 2023, v. 30, n. 1, p. 78, doi. 10.1159/000527853
- By:
- Publication type:
- Article